History
2014:
DPE (Deutsche Private Equity) acquires PharmaZell.
2013:
PharmaZell takes over the former Abbott facility in Liestal/Switzerland.
2011:
Ergon Capital Partners (Belgium) acquires Pharmazell and integrates them together with Farmabios (Italy) to Zellbios S.A.
2010:
Pharmazell launches its formulation R&D unit in Vizag, India with lab and pilot scale formulation development.
2009:
PharmaZell starts a new small scale production unit in Vizag.
2008:
PharmaZell builds a new production plant in Vizag (India) and the production of Mesalamine starts. PharmaZell opens a new R&D center in Vizag as well.
2006:
Today‘s PharmaZell is created through a management buyout of the Noveon pharmaceutical business with the help of private equity investor Auctus. The Raubling headquarters near Munich become the Company‘s registered office.
2001:
The performance material segment is spun off from BF Goodrich under the name of Noveon, with the active pharmaceutical ingredients business now being managed as Noveon GmbH & Co. KG.
1998:
BF Goodrich acquires the Freedom Chemical Company.
1995:
Diamalt builds its first production site in Chennai (the former Madras) in India to produce Cysteine products.
1994:
Diamalt is acquired by Freedom Chemical Company and continues to be run under its old name of Diamalt GmbH.
1979:
Schering AG, a pharmaceutical company, acquires a majority of Diamalt shares and begins actively investing into Raubling. The company is steadily growing.
1969:
More or less 20 years after the company‘s foundation, PharmaZell gets acquired – the first of several acquisitions
to follow. Diamalt AG buys PharmaZell and expands the site‘s chemical operations.
1947:
The name PharmaZell appears: PharmaZell is newly established in Raubling as a subsidiary of Aschaffenburger
Zellstoffwerke AG paper mill near Munich and begins producing active pharmaceutical ingredients.